Read More

Why IGC Pharma Stock Is Moving Higher

IGC Pharma highlighted data from a trial in which the group treated with TGR-63 showed a 78% and 85% reduction in the cortical and hippocampal amyloid load, respectively, reaffirming its potential to thwart the progression of Alzheimer's disease. IGC Pharma stated it hopes to progress TGR-63 into human trials.

IGC

Read More

What’s Going On With Snowflake Stock?

Several analysts have recently updated their coverage on Snowflake, including: Truist Securities analyst Ki Bin Kim maintained Snowflake with a Buy and raised the price target from $210 to $230. Needham analyst Mike Cikos reiterated Snowflake with a Buy and maintained a $225 price target. Barclays analyst Raimo Lenschow downgraded Snowflake from Overweight to Equal-Weight and announced a $198 price target.

SNOW

Read More

What’s Going On With PayPal Stock?

PayPal will be hosting an keynote, PayPal First Look, at 12:30 p.m. ET on Jan. 25 to discuss first innovations PayPal and Venmo are piloting and bringing to market this year. "Twenty-five years ago, at the dawn of the internet, PayPal was created and e-commerce was born – fast forward through decades of innovation and unimaginable growth, PayPal is leading the way to provide safe, secure experiences to customers around the world," said Alex Chriss, CEO of PayPal.

PYPL